Skip to main content
. Author manuscript; available in PMC: 2021 Jul 8.
Published in final edited form as: Mol Psychiatry. 2021 Jan 8;26(3):917–926. doi: 10.1038/s41380-020-00990-2

Table 2:

Effects of OCPs on menstrual-related mood and physical symptoms.

DRSP Item OCP arm: Mean ± Standard Deviation Placebo arm: Mean ± Standard Deviation p-value (OCP arm vs. placebo arm) Cohen’s d
1. Felt depressed 1.940 ± 0.919 1.625 ± 0.600 0.115 0.41
2. Felt anxious 2.007 ± 0.895 1.831 ± 0.600 0.350 0.23
3. Mood swings 1.998 ± 0.945 1.607 ± 0.609 0.075 0.49
4. Felt angry 1.892 ± 0.890 1.630 ± 0.606 0.192 0.34
5. Less interest 1.981 ± 0.958 1.622 ± 0.609 0.056 0.45
6. Difficulty concentrating 2.014 ± 1.081 1.708 ± 0.619 0.123 0.35
7. Fatigue 2.421 ± 1.202 2.150 ± 2.150 0.323 0.16
8. Increased appetite 2.089 ± 1.181 1.789 ± 0.715 0.209 0.31
9. Slept more 2.168 ± 1.330 1.875 ± 0.870 0.302 0.26
10. Felt overwhelmed 1.830 ± 0.861 1.501 ± 0.523 0.048* 0.46
11. Physical symptoms 2.166 ± 1.022 1.475 ± 0.443 0.0009*** 0.88
12. Reduced productivity 1.920 ± 0.921 1.462 ± 0.496 0.014* 0.62
13. Social avoidance 1.671 ± 0.745 1.347 ± 0.399 0.050 0.54
14. Relationship problems 1.598 ± 0.672 1.364 ± 0.478 0.136 0.40